Lyfebulb
Entity
Description
  • Value proposition

    Connect People. Inspire Change. Impact Lives.

    Lyfebulb is a chronic disease focused, patient empowerment platform that connects patients, industry and investors to support user-driven innovation.

    Health, Diabetes, Chronic Disease, Wellness, Investing, Finance, Cancer, Inflammatory Bowel Disease, Entrepreneurship, and Chronic Illness

  • Lyfebulb

    Our mission at Lyfebulb is to reduce the burden of living with chronic disease through the power of the patient. Learn more here.

    • https://lyfebulb.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Blue Horizon
Blue Horizon
Venture Capital and Private Equity Principals
Blue Horizon
Venture Capital and Private Equity Principals 		Other

30 Apr 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing 		Not capitalistic
Partnership
Event

16 Nov 2022


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Not capitalistic
Not partnership
Event

8 Nov 2017


Google
Google
IT services, Software Development
Google
IT services, Software Development 		Not capitalistic
Partnership
Not event

27 Apr 2020


Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development 		Other

8 Jun 2020


Similar entities
Last news
Show all articles
Social network dynamics